Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Baimeite Biopharmaceutical is a China-based biotechnology company focused on the research, development, and industrialization of high-end complex formulations and long-acting sustained-release drugs. The company specializes in advanced drug delivery systems, including microspheres, liposomes, and implants, to enhance the therapeutic profile of peptides and small molecules. Its robust pipeline targets significant unmet needs in metabolic diseases, psychiatry, and oncology, with lead programs in late-stage clinical development. Baimeite maintains state-of-the-art R&D and manufacturing facilities that adhere to global GMP standards. The company's mission is to provide high-quality, innovative pharmaceutical products that improve patient compliance and clinical outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Baimeite Biopharmaceutical.